To comply with US Food and Drug Administration (FDA) guidelines of MRI safety, we propose a method to simulate Specific Absorption Rate (SAR) information with bilateral breast phantoms seamlessly integrated to a human model. This modeling method can be used with various breast phantoms. The simulation results indicate breasts with high glandular contents are more susceptible to SAR safety concerns compared to breasts with low glandular content.
This abstract and the presentation materials are available to members only; a login is required.